Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Northwestern University |
---|---|
Information provided by: | Northwestern University |
ClinicalTrials.gov Identifier: | NCT00262977 |
Our aim is to determine if a patient-directed intervention is more effective than computerized clinician reminders alone for improving aspirin use in adults with diabetes.
Condition | Intervention |
---|---|
Diabetes Mellitus |
Behavioral: Electronic prompt plus patient-directed intervention Behavioral: Electronic prompt to clinician to prescribe aspirin |
Study Type: | Interventional |
Study Design: | Educational/Counseling/Training, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Improving Appropriate Aspirin Use Among Adults With Diabetes in a Primary Care Setting: Using an Electronic Medical Record to Target a Physician-Supervised Nurse Practitioner Intervention |
Estimated Enrollment: | 300 |
Study Start Date: | September 2004 |
Estimated Study Completion Date: | May 2005 |
Many patients with diabetes do not use aspirin to prevent cardiovascular events. Quality improvement initiatives involving both patients and physicians may be more effective than physician-directed approaches alone.
In a large urban primary care internal medicine practice, this study seeks to test if a patient-directed intervention is more effective than computerized clinician reminders alone for improving the appropriate use of aspirin in adults with diabetes.
The study design is a cluster-randomized trial by physician. The frequency of self-reported regular aspirin use will be compared beteween patients cared for by physicians in the computerized reminder alone group and the computerized reminder plus physician-supervised, nurse practitioner intervention group.
Ages Eligible for Study: | 40 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Diabetes mellitus
Exclusion Criteria:
United States, Illinois | |
Northwestern University, Division of General Internal Medicine | |
Chicago, Illinois, United States, 60611 |
Principal Investigator: | Stephen D Persell, MD, MPH | Northwestern University |
Study ID Numbers: | 1402-001 |
Study First Received: | December 5, 2005 |
Last Updated: | December 5, 2005 |
ClinicalTrials.gov Identifier: | NCT00262977 |
Health Authority: | United States: Institutional Review Board |
diabetes mellitus cardiovascular diseases aspirin quality of healthcare |
Metabolic Diseases Aspirin Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Metabolic disorder Glucose Metabolism Disorders |
Anti-Inflammatory Agents Molecular Mechanisms of Pharmacological Action Cyclooxygenase Inhibitors Hematologic Agents Physiological Effects of Drugs Enzyme Inhibitors Fibrinolytic Agents Cardiovascular Agents Pharmacologic Actions Fibrin Modulating Agents |
Analgesics, Non-Narcotic Sensory System Agents Therapeutic Uses Platelet Aggregation Inhibitors Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents |